Busulfan–melphalan in High-Risk Neuroblastoma: The 30-Year Experience of a Single Institution

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2016.75
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search